Skip to main content
Clinical Trials/NCT06178029
NCT06178029
Completed
Not Applicable

Effectiveness of Acupuncture Treatment Applied in Addition to the Rehabilitation Program in Multiple Sclerosis Patients

Ankara City Hospital Bilkent1 site in 1 country40 target enrollmentJune 18, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Ankara City Hospital Bilkent
Enrollment
40
Locations
1
Primary Endpoint
Timed 25 Foot Walk Test Score
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of the study is to assess the effect of acupuncture treatment combinated with conventional rehabilitation methods on gait, fatigue, quality of life and bladder functions in patients with multiple sclerosis

Detailed Description

After being informed about study and potential risks, all patient giving written informed consent will undergo screening period determine eligibility for study entry. The patients who meet the eligibility recruitments will get treatment into two groups in a conventional rehabilitation and acupuncture combined with conventional rehabilitation

Registry
clinicaltrials.gov
Start Date
June 18, 2023
End Date
April 15, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Zeynep İnce

Medical Doctor

Ankara City Hospital Bilkent

Eligibility Criteria

Inclusion Criteria

  • Being diagnosed with MS according to McDonald criteria
  • EDSS score between 1-6
  • The patient is clinically stable
  • Having not had a new MS attack in the last 3 months
  • Being cognitively suitable to participate in the study

Exclusion Criteria

  • Being clinically unstable
  • Inability to cognitively participate in tests
  • Having received acupuncture treatment in the last 6 months

Outcomes

Primary Outcomes

Timed 25 Foot Walk Test Score

Time Frame: Baseline, after 1 month and 3 month changes

The Timed 25 Foot Walk test assesses a patient's ability to walk 25 feet distance.Patient's walking speed in m/s calculate

Secondary Outcomes

  • Neurogenic Bladder Symptom Scoring(Baseline, after 1 month and 3 month changes)
  • Fatigue Severity Scale(Baseline, after 1 month and 3 month changes)
  • Incontinence Quality of Life Questionnaire(Baseline, after 1 month and 3 month changes)
  • Multiple Sclerosis Quality of Life-54 (MSQOL-54)(Baseline, after 1 month and 3 month changes)

Study Sites (1)

Loading locations...

Similar Trials